HNP Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
HNP Capital's PFE Position: Q1 2023 in Review
HNP Capital reduced its Pfizer (PFE) stake by 3.4% in Q1 2023, selling an estimated $24.7K and leaving 16,075 shares worth $656K. The position accounts for 0.18% of the portfolio, ranked #92.
HNP Capital first reported a position in PFE in Q4 2018 and has held it in 18 quarters since. The position peaked at $4.35M in Q1 2020. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.
- HNP Capital held 16,075 shares of Pfizer worth $656K as of Q1 2023.
- HNP Capital sold 571 Pfizer shares in Q1 2023, an estimated $24.7K.
- Pfizer made up 0.18% of HNP Capital's portfolio in Q1 2023, its #92 holding.
- HNP Capital first reported a position in Pfizer in Q4 2018 and has held it in 18 quarters since.
- HNP Capital's Pfizer position peaked at $4.35M in Q1 2020.
- 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.
Based on HNP Capital's 13F filing for Q1 2023, filed 18 May 2023.